Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
Total
Ordinary Shares
Reserves
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total Stockholders' Equity (Virax)
Non Controlling Interest
Number of shares, beginning balance at Mar. 31, 2021   9,231,022            
Equity, beginning balance at Mar. 31, 2021 $ (831,814) $ 924 $ 4,033,794 $ (54,497) $ (4,628,139) $ (2,764) $ (650,682) $ (181,132)
Shares issued for cash, shares   238,906            
Shares issued for cash 519,613 $ 24 519,589       519,613  
Shares issued for services, shares   346,356            
Shares issued for services 290,364 $ 35 290,329       290,364  
Shares issued for settlement of related party payable, shares   172,532            
Shares issued for settlement of related party payable 452,861 $ 17 452,844       452,861  
Shares issued for conversion of convertible debt. shares   37,735            
Shares issued for conversion of convertible debt 100,000 $ 4 99,996       100,000  
Surrender of ViraxClear Shares, shares   (50,000)            
Surrender of ViraxClear Shares   $ (5) (54,492) $ 54,497        
Imputed interest 21,128   21,128       21,128  
Foreign currency adjustment 1,010         965 965 45
Net Loss $ (1,749,870)       (1,708,827)   (1,708,827) (41,043)
Number of shares, ending balance at Mar. 31, 2022 9,976,551 9,976,551            
Equity, ending balance at Mar. 31, 2022 $ (1,196,708) $ 999 5,363,188   (6,336,966) (1,799) (974,578) (222,130)
Shares issued for cash, shares   4,257,500            
Shares issued for cash 13,654,215 $ 426 13,653,789       13,654,215  
Shares issued for services, shares   7,547            
Shares issued for services 20,000 $ 1 19,999       20,000  
Shares issued for settlement of related party payable, shares   54,300            
Shares issued for settlement of related party payable 39,863 $ 5 39,858       39,863  
Contributions 109,570   109,570       109,570  
Cashless warrant exercise, shares   86,191            
Cashless warrant exercise 9 $ 9         9  
Pre-funded warrant exercise, shares   1,165,000            
Pre-funded warrant exercise 117 $ 117         117  
Stock-based compensation 1,734,601   1,734,601       1,734,601  
Foreign currency adjustment 111         111 111  
Net Loss $ (5,457,763)       (5,457,494)   (5,457,494) (269)
Number of shares, ending balance at Mar. 31, 2023 15,547,089 15,547,089            
Equity, ending balance at Mar. 31, 2023 $ 8,904,015 $ 1,557 $ 20,921,005   $ (11,794,460) $ (1,688) $ 9,126,414 $ (222,399)